Bullous Pemphigoid (BP) Completed Phase 4 Trials for Omalizumab (DB00043)

Also known as: Pemphigoid, Bullous / Bullous Pemphigoid / Pemphigoid / Bullous pemphigoid NOS

IndicationStatusPhase
DBCOND0074370 (Bullous Pemphigoid (BP))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00472030Efficacy and Safety of Omalizumab in Bullous PemphigoidTreatment